|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 192.20 SEK | +1.37% |
|
+1.32% | -3.66% |
| 17/06 | Lannebo Sverige Plus increased by 4.3 percent in May – rising profitability at Elekta | FW |
| 13/06 | BioArctic to Advance Parkinson's Disease Drug Trial After Positive Safety Review | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability (Composite) | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
| 173.52Cr | ||||||
| 5.05TCr | ||||||
| 3.31TCr | ||||||
| 2.82TCr | ||||||
| 2.74TCr | ||||||
| 1.26TCr |
- Stock Market
- Equities
- BIOA B Stock
- Charts BioArctic AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition